Malondialdehyde, the end product of lipid peroxidation, has been shown to stimulate collagen ␣1(I) (Col1a1) gene expression. However, mechanisms of this effect are unclear. The purpose of this study was to clarify these mechanisms. Rat hepatic stellate cells were cultured in the presence of 200 M malondialdehyde, and the effects on collagen gene expression and the binding of nuclear proteins to the col1a1 promoter were analyzed. Malondialdehyde treatment induced an increase in the cellular levels of col1a1 mRNA that was abrogated by pretreating cells with cycloheximide, p-hydroxymercuribenzoate, pyridoxal 5-phosphate, and mithramycin. Transient transfections showed that malondialdehyde exerted its effect through regulatory elements located between ؊220 and ؊110 bp of the col1a1 promoter. Gel retardation assays demonstrated that malondialdehyde increased the binding of nuclear proteins to two elements located between ؊161 and ؊110 bp of the col1a1 promoter. These bindings were supershifted with Sp1 and Sp3 antibodies. Finally, malondialdehyde increased cellular levels of the Sp1 and Sp3 proteins and Sp1 mRNA. Our data indicated that treatment of hepatic stellate cells with malondialdehyde stimulated col1a1 gene expression by inducing the synthesis of Sp1 and Sp3 and their binding to two regulatory elements located between ؊161 and ؊110 bp of the col1a1 promoter.Lipid peroxidation by-products, particularly reactive aldehydes, such as malondialdehyde (MDA) 1 and 4-hydroxy-2-nonenal (4HNE), have been incriminated in the pathogenesis of liver fibrosis. Thus, Chojkier et al.(1) first showed that MDA increased significantly the collagen ␣1(I) (Col1a1) mRNA in cultured human fetal fibroblasts, and Maher et al. (2) found that collagen synthesis doubled in response to MDA in rat kidney fibroblasts. Likewise, Parola et al. (3,4) showed that 4HNE and other 4-hydroxy-2,3-alkenals, aldehydic end products of lipid peroxidations, were able to stimulate col1a1 gene expression and collagen synthesis in cultured hepatic stellate cells (HSC). Similar results have been reported by Tsukamoto and co-workers (5, 6), who also observed a significant correlation between the liver MDA and 4HNE levels and the hepatic collagen accumulation in a rat model of alcoholic liver disease.Mechanisms by which these reactive aldehydes induce col1a1 gene expression and synthesis are still unclear. However, a number of studies have provided evidence supporting the role of aldehyde-protein adducts in the regulation of col1a1 gene expression. These aldehydes are known to react with sulfhydryl or amino groups to form aldehyde-protein adducts (7). These adducts have been found in alcoholic liver disease (8, 9) and other clinical conditions of chronic liver injury associated with active fibrogenesis, as well as in animal models of lipid peroxidation (6, 10 -14). Moreover, antioxidant treatment significantly decreased the production of these adducts and prevented the fibrogenesis cascade (10, 13, 15). The purpose of this study was to clarify the mechanisms ...
The purpose of this study was to identify the cis-acting elements and the trans-acting factors involved in the iron-induced expression of the collagen alpha1(I) (COL1aI) gene. Rat hepatic stellate cells were cultured in the presence of 50 microM ferric chloride, 50 microM ascorbic acid, and 250 microM citric acid (Fe/AA/CA), and the effects on collagen gene expression and the binding of nuclear proteins to the COL1aI promoter were measured. The Fe/AA/CA treatment induced a time- and dose-dependent increase in the cellular levels of COL1aI mRNA that was abrogate by pretreating cells with cycloheximide, antioxidants, and inhibitors of aldehyde-protein adduct formation. Transient transfection experiments showed that Fe/AA/CA exerted its effect through regulatory elements located between -220 and -110 bp of the COL1aI promoter. Gel retardation assays showed that Fe/AA/CA increased the binding of nuclear proteins to two elements located between -161 and -110 bp of the COL1aI promoter. These bindings were blocked by unlabeled consensus Sp1 oligonucleotide and supershifted with Sp1 and Sp3 antibodies. Finally, Fe/AA/CA increased cellular levels of the Sp1 and Sp3 proteins and Sp1 mRNA. Treatment with Fe/AA/CA stimulates COL1aI gene expression by inducing the synthesis of Sp1 and Sp3 and their binding to two regulatory elements located between -161 and -110 bp of the COL1aI promoter.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.